These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 52936)

  • 21. One-week use of oxymetazoline nasal spray in patients with rhinitis medicamentosa 1 year after treatment.
    Graf P; Hallén H
    ORL J Otorhinolaryngol Relat Spec; 1997; 59(1):39-44. PubMed ID: 9104748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [On the absorption of decongestive nose-drops-investigation with a radioactive labelled imidazoline-derivate (author's transl)].
    Münzel M; Eichner H
    Laryngol Rhinol Otol (Stuttg); 1975 Nov; 54(11):875-88. PubMed ID: 53769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rhinitis medicamentosa.
    Ramey JT; Bailen E; Lockey RF
    J Investig Allergol Clin Immunol; 2006; 16(3):148-55. PubMed ID: 16784007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uses and ability of chilies in reducing mucus congestion.
    Akhtar A; Ali MK
    J Pak Med Assoc; 2013 Feb; 63(2):303. PubMed ID: 23894924
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of nasal decongestants on locomotor activity of the ciliary apparatus of nasal mucosa in patients with acute purulent rhinosinusitis].
    Kramnoĭ AI; Kozlov VS
    Vestn Otorinolaringol; 2010; (1):67-8. PubMed ID: 20436429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel.
    Mortuaire G; de Gabory L; François M; Massé G; Bloch F; Brion N; Jankowski R; Serrano E
    Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Jun; 130(3):137-44. PubMed ID: 23375990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical test of oxymetazoline-HCl-nose drops for infants (Nasivin 0,01 per cent)].
    Rüggeberg F
    Z Allgemeinmed; 1974 Apr; 50(11):535-7. PubMed ID: 4135074
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of different preparations of nasal decongestants on ciliary beat frequency in vitro.
    Deitmer T; Scheffler R
    Rhinology; 1993 Dec; 31(4):151-3. PubMed ID: 7511251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of a synthetic prostaglandin and xylometazoline hydrochloride as nasal decongestants.
    Jackson RT; Birnbaum JE
    Otolaryngol Head Neck Surg; 1982; 90(5):595-7. PubMed ID: 6186975
    [No Abstract]   [Full Text] [Related]  

  • 30. [Corticosteroid is efficient against abuse of nasal decongestants].
    Graf P; Enerdal J; Hallén H
    Lakartidningen; 1998 Sep; 95(40):4344-6. PubMed ID: 9800453
    [No Abstract]   [Full Text] [Related]  

  • 31. Exploratory study of the decongestive effect of Rhinopront syrup in adults and in children with acute rhinitis.
    Lebacq E; Gline JP; Joue P; Stockis A; Calderon P; Van Schoor O; Deroubaix X; Schwegler F
    Clin Trials Metaanal; 1994 Oct; 29(2-3):113-24. PubMed ID: 10151073
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of acute nonspecific rhinitis. Studies on the long-term effect of Cimporhin].
    Hinkelmann B
    Fortschr Med; 1972 Sep; 90(26):957-8. PubMed ID: 4118117
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of decongestive nosedrops on human respiratory mucosa in vitro.
    Berg OH; Lie K; Steinsvåg SK
    Laryngoscope; 1994 Sep; 104(9):1153-8. PubMed ID: 7520965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Electron microscopic studies of the rabbit nasal mucosa after short-term application of naphzoline nitrate].
    Agha-Mir-Salim P; Stange T; Knipping S; Jahnke V; Berghaus A
    Laryngorhinootologie; 2001 Jul; 80(7):389-93. PubMed ID: 11488150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [On the vaso-active therapy of the nasal mucosa with a new adrianol-imidazoline combination].
    Küspert A
    Med Welt; 1965 Nov; 45():2563-4. PubMed ID: 5886326
    [No Abstract]   [Full Text] [Related]  

  • 36. Correlation between objective nasal mucosal swelling and estimated stuffiness during long-term use of vasoconstrictors.
    Graf P; Juto JE
    ORL J Otorhinolaryngol Relat Spec; 1994; 56(6):334-9. PubMed ID: 7530821
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of protective and therapeutic effects of dexpanthenol on nasal decongestants and preservatives: results of cytotoxic studies in vitro.
    Klöcker N; Rudolph P; Verse T
    Am J Rhinol; 2004; 18(5):315-20. PubMed ID: 15586804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Rhinitis medicamentosa].
    Finsnes KA
    Tidsskr Nor Laegeforen; 1987 Jun; 107(17-18):1558-9. PubMed ID: 2440127
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experience in the use of a nose drop, Otrivin].
    Mizukoshi O; Sasaki H; Imamura C; Kawamoto A; Hama H
    Jibiinkoka; 1967 Sep; 39(9):1021-114. PubMed ID: 4170718
    [No Abstract]   [Full Text] [Related]  

  • 40. Function and structure of the nasal mucosa after 6 weeks' use of nose-drops.
    Petruson B; Hansson HA
    Acta Otolaryngol; 1982; 94(5-6):563-9. PubMed ID: 6184941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.